Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ABBV-461 |
| Synonyms | |
| Therapy Description |
ABBV-461 comprises an antibody fragment targeting an undisclosed tumor-associated antigen linked to a peptide epitope that is recognized by CRBL001 CAR-T cells, which potentially induces activation of CRBL001 CAR-T cells and tumor cell killing (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ABBV-461 | ABBV 461|ABBV461 | ABBV-461 comprises an antibody fragment targeting an undisclosed tumor-associated antigen linked to a peptide epitope that is recognized by CRBL001 CAR-T cells, which potentially induces activation of CRBL001 CAR-T cells and tumor cell killing (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|